

Panel: AI's Impact on Pharma & Biotech: Advantages and Challenges
Thursday, August 19, 2021 7:00 PM to 7:50 PM · 50 min. (Africa/Abidjan)
Information
As the pandemic has demonstrated, the success of pharmaceutical and biotechnology companies plays a vital role in the overall wellbeing of our society. AI has opened the door for new opportunities in the areas of drug discovery, clinical trials, patient engagement, and organizational efficiency. This panel will gather executives & technologists at leading pharma and biotech companies who are developing robust AI projects.
Speakers

Philippe Moingeon
Head of ImmunoinflammationServier
Rohit Mahajan
Co-Founder and President, Citadel Discovery and Managing Partner BigRioCitadel DiscoveryFK
Faisal Khan
Executive Director, AI and AnalyticsAstra Zeneca
Tatiana Sorokina
Solutions Director, Data Science & Artificial IntelligenceNovartis
Ed Downs
Sr Product Marketing ManagerSinequa


